Clinical Studies

Overview

Epiretinal beta radiation therapy is approved for the treatment of wet age-related macular degeneration (AMD) in the European Union; in the United States it is an investigational treatment at this time, and is being studied in several clinical trials, including CABERNET. Follow the links to learn more about each of these unique studies.

CABERNET

ROSÉ

MERITAGE

MERLOT

NVI-111

NVI-068